4519.T
Chugai Pharmaceutical Co., Ltd.$7,550.00
+0.48%Jun 19, 2026
Market cap
$12.36T
52w range
—
P / E
—
EPS · FY 2025
$263.72
Volume
—
Revenue · FY 2025
$1.26T
+7.46% YoY
Explain this page
Arphra AIPlain-English read on Chugai Pharmaceutical Co., Ltd.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$7,170.64
— vs spot
Recommendation
n/a
4 of 4 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →4519.T
7,550+0.53%H 10,700L 5,942MA50 8,017MA200 8,039Avg vol 2.8M
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $321.75B | $115.42B | $70.13 |
| Q4 Dec 2025 | $346.3B | $128.41B | $78.03 |
| Q3 Sep 2025 | $333.18B | $111.21B | $67.58 |
| Q2 Jun 2025 | $290.01B | $97.16B | $59.04 |
| Q1 Mar 2025 | $288.46B | $97.23B | $59.08 |
| Q4 Dec 2024 | $302.07B | $91.6B | $55.64 |
Sector & industry today
LiveSectors
- Real Estate+1.26%
- Industrials+1.00%
- Basic Materials+0.65%
- Energy+0.59%
- Healthcare+0.01%
- Utilities-0.07%
- Financial Services-0.24%
- Communication Services-0.55%
- Technology-0.80%
- Consumer Cyclical-0.85%
- Consumer Defensive-1.00%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-0.19%
- Biotechnology+6.56%
- Financial - Mortgages-4.05%
- Electrical Equipment & Parts+3.88%
- Staffing & Employment Services-3.62%
- Software - Services-3.30%
- Software - Infrastructure-3.07%
- Advertising Agencies+2.92%
- Apparel - Footwear & Accessories-2.80%
- Engineering & Construction+2.80%
- Financial - Conglomerates+2.62%
- Luxury Goods+2.47%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for 4519.T.
Peers
No peer list available for 4519.T.
Total assets
$2.47T
Total debt
$0
Cash & equiv
$426.6B
Operating CF
$389.45B
Free cash flow
$313.18B
Buybacks
-$6M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $1.26T | $590.19B | $434.01B | $263.72 | +34.50% |
| FY 2024 | $1.17T | $543.91B | $387.32B | $235.36 | +33.09% |
| FY 2023 | $1.11T | $415.67B | $325.47B | $197.80 | +29.29% |
| FY 2022 | $1.26T | $533.94B | $374.43B | $227.57 | +29.72% |
| FY 2021 | $999.76B | $433.74B | $303B | $184.17 | +30.31% |